AI English summary of an SEC filing — figures as filed
TransDigm said net sales for fiscal 2025 Q2 ended March 29, 2025 were $2,150 million, up 12.0% from $1,919 million in the prior year's quarter, and net income was $479 million, up 18.6% from $404 million in the prior year's quarter.
Key points
AI summaryTransDigm said net sales for fiscal 2025 Q2 ended March 29, 2025 were $2,150 million, up 12.0% from $1,919 million in the prior year's quarter, and net income was $479 million, up 18.6% from $404 million in the prior year's quarter.
The company said EBITDA As Defined for Q2 was $1,162 million, up 13.8% from $1,021 million in the comparable prior year period, and EBITDA As Defined as a percentage of net sales was 54.0% compared with 53.2% in the comparable prior year period.
TransDigm said it repurchased 42,669 shares of its common stock at an average price per share of $1,249.52 for a total amount of approximately $53 million during fiscal 2025 Q2, and subsequent to quarter-end, in April 2025, it repurchased 105,567 shares at an average price per share of $1,240.91 for a total amount of approximately $131 million.
The company said it is maintaining its previously issued fiscal 2025 financial guidance, which was stated on February 4, 2025, for net sales of $8,750 million to $8,950 million and adjusted earnings per share of $35.51 to $37.43. It said the guidance incorporates the impact of recently enacted U.S. and non-U.S. tariffs.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Fiscal 2025 Q2 Net Sales $2,150 million, Net Income $479 million
TransDigm said net sales for fiscal 2025 Q2 ended March 29, 2025 were $2,150 million, up 12.0% from $1,919 million in the prior year's quarter, and net income was $479 million, up 18.6% from $404 million in the prior year's quarter.
Source · Based on the filing body and exhibits
EBITDA As Defined $1,162 million, Margin 54.0%
The company said EBITDA As Defined for Q2 was $1,162 million, up 13.8% from $1,021 million in the comparable prior year period, and EBITDA As Defined as a percentage of net sales was 54.0% compared with 53.2% in the comparable prior year period.
Source · Based on the filing body and exhibits
Q2 Share Repurchases Approximately $53 million, $131 million Subsequent to Quarter-End
TransDigm said it repurchased 42,669 shares of its common stock at an average price per share of $1,249.52 for a total amount of approximately $53 million during fiscal 2025 Q2, and subsequent to quarter-end, in April 2025, it repurchased 105,567 shares at an average price per share of $1,240.91 for a total amount of approximately $131 million.
Source · Based on the filing body and exhibits
Fiscal 2025 Guidance Maintained: Net Sales $8,750 to 8,950 million
The company said it is maintaining its previously issued fiscal 2025 financial guidance, which was stated on February 4, 2025, for net sales of $8,750 million to $8,950 million and adjusted earnings per share of $35.51 to $37.43. It said the guidance incorporates the impact of recently enacted U.S. and non-U.S. tariffs.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…